ClinicalTrials.gov record
Completed Phase 3 Interventional

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

ClinicalTrials.gov ID: NCT00026286

Public ClinicalTrials.gov record NCT00026286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 2:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Prospective, Randomized, Double-Blind Clinical Trial of Hormone Replacement Therapy In Postmenopausal Women With A History Of Node-Negative Or Ductal Carcinoma In Situ Who Are Receiving Adjuvant Tamoxifen

Study identification

NCT ID
NCT00026286
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • conjugated estrogens Drug
  • medroxyprogesterone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2000
Primary completion
Jul 31, 2002
Completion
Jun 14, 2007
Last update posted
Jun 14, 2023

2000 – 2007

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611-3013
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611
CCOP - Central Illinois Decatur Illinois 62526
CCOP - Carle Cancer Center Urbana Illinois 61801
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
CCOP - Northern New Jersey Hackensack New Jersey 07601
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461
CCOP - Merit Care Hospital Fargo North Dakota 58122
Ireland Cancer Center Cleveland Ohio 44106-5065
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104-4283
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
CCOP - MainLine Health Wynnewood Pennsylvania 19096
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104
Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus Nashville Tennessee 37212
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00026286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00026286 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →